Literature DB >> 6338113

Use of UV-irradiated bacteriophage T6 to kill extracellular bacteria in tissue culture infectivity assays.

D R Shaw, A T Maurelli, J D Goguen, S C Straley, R Curtiss.   

Abstract

We have utilized 'lysis from without' mediated by UV-inactivated bacteriophage T6 to eliminate extracellular bacteria in experiments measuring the internalization, intracellular survival and replication of Yersinia pestis within mouse peritoneal macrophages and of Shigella flexneri within a human intestinal epithelial cell line. The technique we describe has the following characteristics: (a) bacterial killing is complete within 15 min at 37 degrees C, with a greater than 10(3)-fold reduction in colony-forming units (CFU); (b) bacteria within cultured mammalian cells are protected from killing by UV-inactivated T6; (c) the mammalian cells are not observably affected by exposure to UV-inactivated T6. This technique has several advantages over the use of antibiotics to eliminate extracellular bacteria and is potentially widely applicable in studies of the interactions between pathogenic bacteria and host phagocytic cells as well as other target tissues.

Entities:  

Mesh:

Year:  1983        PMID: 6338113     DOI: 10.1016/0022-1759(83)90050-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Growth in mouse peritoneal macrophages of Yersinia pestis lacking established virulence determinants.

Authors:  S C Straley; P A Harmon
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

2.  Influence of extracellular bactericidal agents on bacteria within macrophages.

Authors:  Terri S Hamrick; Adam H Diaz; Edward A Havell; John R Horton; Paul E Orndorff
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

Review 3.  Bacteriophage interactions with phagocytes and their potential significance in experimental therapy.

Authors:  Aneta Kurzepa; Krystyna Dabrowska; Grzegorz Skaradziński; Andrzej Górski
Journal:  Clin Exp Med       Date:  2009-01-30       Impact factor: 3.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.